Literature DB >> 2675782

Immunolocalization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): correlation with rheumatoid arthritis.

Y Okada1, N Takeuchi, K Tomita, I Nakanishi, H Nagase.   

Abstract

Metalloproteinases produced by connective tissue cells may play a key part in the destruction of joints in rheumatoid arthritis. Matrix metalloproteinase 3 (MMP-3; stromelysin) capable of degrading cartilage proteoglycans and type IX collagen and of activating procollagenase was immunolocalised in hyperplastic synovial lining cells in rheumatoid synovium, but not in the cells of normal synovium. Cells responsible for synthesis of MMP-3 have the phenotype of synovioblasts (B cells) by immunoelectron microscopy, but not of phagocytic synovial macrophages (A cells). Cultured monolayer of rheumatoid synovial cells synthesises MMP-3 only under treatment with macrophage conditioned medium. Immunolocalisation of MMP-3 in rheumatoid synovium and cultured synovial cells was possible when the specimens were treated with a monovalent ionophore, monensin. These results suggest that MMP-3 is synthesised and secreted continuously without storage from hyperplastic synovioblasts stimulated by factor(s) derived from activated macrophages present in the synovium.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2675782      PMCID: PMC1003840          DOI: 10.1136/ard.48.8.645

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  40 in total

1.  An endopeptidase from rheumatoid synovial tissue culture.

Authors:  E D Harris; S M Krane
Journal:  Biochim Biophys Acta       Date:  1972-02-28

2.  Type-specific collagenolysis: a type V collagen-degrading enzyme from macrophages.

Authors:  C L Mainardi; J M Seyer; A H Kang
Journal:  Biochem Biophys Res Commun       Date:  1980-12-16       Impact factor: 3.575

3.  The degradation of cartilage proteoglycans by tissue proteinases. Proteoglycan heterogeneity and the pathway of proteolytic degradation.

Authors:  P J Roughley
Journal:  Biochem J       Date:  1977-12-01       Impact factor: 3.857

4.  Purification of rheumatoid synovial collagenase and its action on soluble and insoluble collagen.

Authors:  D E Woolley; R W Glanville; M J Crossley; J M Evanson
Journal:  Eur J Biochem       Date:  1975-06

5.  Production of collagenase and prostaglandins by isolated adherent rheumatoid synovial cells.

Authors:  J M Dayer; S M Krane; R G Russell; D R Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  1976-03       Impact factor: 11.205

6.  Degradation of cartilage proteoglycan by human leukocyte granule neutral proteases--a model of joint injury. II. Degradation of isolated bovine nasal cartilage proteoglycan.

Authors:  H Keiser; R A Greenwald; G Feinstein; A Janoff
Journal:  J Clin Invest       Date:  1976-03       Impact factor: 14.808

Review 7.  The possible role of neutrophil proteinases in damage to articular cartilage.

Authors:  A J Barrett
Journal:  Agents Actions       Date:  1978-01

8.  Collagenases in human synovial fluid.

Authors:  E D Harris; D R DiBona; S M Krane
Journal:  J Clin Invest       Date:  1969-11       Impact factor: 14.808

9.  Collagenase at sites of cartilage erosion in the rheumatoid joint.

Authors:  D E Woolley; M J Crossley; J M Evanson
Journal:  Arthritis Rheum       Date:  1977 Jul-Aug

10.  Immunocytochemical localization of procollagen and fibronectin in human fibroblasts: effects of the monovalent ionophore, monensin.

Authors:  P W Ledger; N Uchida; M L Tanzer
Journal:  J Cell Biol       Date:  1980-12       Impact factor: 10.539

View more
  51 in total

1.  Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis.

Authors:  Y Yoshihara; H Nakamura; K Obata; H Yamada; T Hayakawa; K Fujikawa; Y Okada
Journal:  Ann Rheum Dis       Date:  2000-06       Impact factor: 19.103

2.  Physiological matrix metalloproteinase concentrations in serum during childhood and adolescence, using Luminex Multiplex technology.

Authors:  Kathryn M Thrailkill; Cindy S Moreau; Gael Cockrell; Pippa Simpson; Rajiv Goel; Paula North; John L Fowlkes; Robert C Bunn
Journal:  Clin Chem Lab Med       Date:  2005       Impact factor: 3.694

3.  Inhibitory effect of cephalothin on matrix metalloproteinase activity around loose hip prostheses.

Authors:  S Santavirta; M Takagi; Y T Konttinen; T Sorsa; A Suda
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

4.  TNF-alpha-mediated expression of membrane-type matrix metalloproteinase in rheumatoid synovial fibroblasts.

Authors:  K Migita; K Eguchi; Y Kawabe; Y Ichinose; T Tsukada; T Aoyagi; H Nakamura; S Nagataki
Journal:  Immunology       Date:  1996-12       Impact factor: 7.397

5.  Matrix metalloproteinase-3-dependent generation of a macrophage chemoattractant in a model of herniated disc resorption.

Authors:  H Haro; H C Crawford; B Fingleton; J R MacDougall; K Shinomiya; D M Spengler; L M Matrisian
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

6.  Increased matrix metalloproteinases as possible cause of osseoarticular tissue destruction in long-term haemodialysis and beta 2-microglobulin amyloidosis.

Authors:  K Ohashi; R Kawai; M Hara; Y Okada; S Tachibana; Y Ogura
Journal:  Virchows Arch       Date:  1996-04       Impact factor: 4.064

7.  Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice.

Authors:  Hiroshi Hata; Noriko Sakaguchi; Hiroyuki Yoshitomi; Yoichiroh Iwakura; Kenji Sekikawa; Yoshiaki Azuma; Chieko Kanai; Eiko Moriizumi; Takashi Nomura; Takashi Nakamura; Shimon Sakaguchi
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

8.  Comparative studies of collagenase and stromelysin-1 expression by rheumatoid synoviocytes in vitro.

Authors:  L C Tetlow; M Lees; D E Woolley
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

9.  Inhibition of MMP-3 activity and invasion of the MDA-MB-231 human invasive breast carcinoma cell line by bioflavonoids.

Authors:  Kanokkarn Phromnoi; Supachai Yodkeeree; Songyot Anuchapreeda; Pornngarm Limtrakul
Journal:  Acta Pharmacol Sin       Date:  2009-07-20       Impact factor: 6.150

Review 10.  Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor.

Authors:  Jean-Michel Dayer; Ernest Choy
Journal:  Rheumatology (Oxford)       Date:  2009-10-23       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.